Oxurion NV: OXURION to Participate in Upcoming Investor Meetings
Oxurion NV: OXURION to Participate in Upcoming Investor Meetings OXURION to Participate in Upcoming Investor Meetings Leuven, BELGIUM, Boston, MA, US - January 7, 2021 - 08.00 AM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard-of-care ophthalmic therapies, with a focus on diabetic macular edema (DME), today announces its management will participate and meet with investors at the following upcoming virtual meetings: · H.C. Wainwright Bioconnect 2021 Conference January 11 - 14, 2021 · BIO Partnering at JPM Week January 1...
Source: finanznachrichten.de